Proliferation parameters in epidermoid carcinomas of the anal canal

Radiotherapy and Oncology

Volumn 56, Issue 3, 2000, Pages 349-353

  Wong, C Shun ^a   Tsang, Richard W ^a   Cummings, Bernard J ^a   Fyles, Anthony W ^a   Couture, Jean ^b   Brierley, James D ^a   Pintilie, Melania ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anal carcinoma; Bromodeoxyuridine; Radiation therapy; Tumor proliferation

Indexed keywords

BROXURIDINE; FLUOROURACIL; MITOMYCIN C;

ADULT; AGE; AGED; ANUS CARCINOMA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENDER; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0034284102     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00213-9     Document Type: Article

References (30)

1. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative groups. J. Clin. Oncol. 15:1997;2040-2049.
2. Begg A.C., Haustermans K., Hart A.A., et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother. Oncol. 50:1999;13-23.
3. Begg A.C., McNally N.J., Shrieve D.C., Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 6:1985;620-626.
4. Bolger B.S., Symonds R.P., Stanton P.D., et al. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. Br. J. Cancer. 74:1996;1223-1226.
5. Boman B.M., Moertel C.G., O'Connell M.J., et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer. 54:1984;114-125.
6. Constantinou E.C., Daly W., Fung C.Y., Willett C.G., Kaufman D.S., DeLaney T.F. Time-dose considerations in the treatment of anal cancer. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;651-657.
7. Cummings B.J. Anal canal cancer-to split or not to split? Cancer J. Sci. Am. 2:1996;194.
8. Cummings J. Anal canal. Perez C., Brady L., Principles and practice of radiation oncology. 1997;1511-1524 Lippincott, Philadelphia, PA.
9. Cummings B.J., Keane T.J., O'Sullivan B., Wong C.S., Catton C.N. Mitomycin in anal canal carcinoma. Oncology. 50:(Suppl 1):1993;63-69.
10. Cummings B.J., Keane T.J., O'Sullivan B., Wong C.S., Catton C.N. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;1115-1125.
11. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J. Clin. Oncol. 14:1996;2527-2539.
12. Frisch M., Glimelius B., van den Brule A.J., et al. Sexually transmitted infection as a cause of anal cancer. N. Engl. J. Med. 337:1997;1350-1358.
13. Fyles A., Keane T.J., Barton M., Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother. Oncol. 25:1992;273-279.
14. Hendry J.H., Roberts S.A., Slevin N.J., Keane T.J., Barton M.B., Agren-Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother. Oncol. 31:1994;14-22.
15. John M., Pajak T., Flam M., et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J. Sci. Am. 2:1996;205.
16. Keane T.J., Cummings B.J., O'Sullivan B., et al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5-fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;613-618.
17. Keane T.J., Harwood A.R., Beale F.A., et al. A pilot study of mitomycin-C/5-fluorouracil infusion combined with split course radiation therapy for carcinomas of the larynx and hypopharynx. J. Otolaryngol. 15:1986;286-288.
18. Melbye M., Rabkin C., Frisch M., Biggar R.J. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am. J. Epidemiol. 139:1994;772-780.
19. Nigro N.D., Vaitkevicius V.K., Considine B. Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis. Colon Rectum. 17:1974;354-356.
20. Papillon J., Montbarbon J.F. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis. Colon Rectum. 30:1987;324-333.
21. UK Co-ordinating Committee on Cancer Research . Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet. 348:1996;1049-1054.
22. Rickert R.R. Disorders of the anal region. Ming S.-C., Goldman H., Pathology of the gastrointestinal tract. 1992;882-903 WB Saunders, Toronto.
23. Robertson C., Robertson A.G., Hendry J.H., et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;319-329.
24. Tanum G., Tveit K., Karlsen K.O., Hauer-Jensen M. Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity. Cancer. 67:1991;2462-2466.
25. pot in cancer of the uterine cervix: preliminary results. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;1319-1329.
26. Tsang R.W., Fyles A.W., Li Y., et al. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables. Radiother. Oncol. 50:1999;85-92.
27. Tsang R.W., Wong C.S., Fyles A.W., et al. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome. Radiother. Oncol. 50:1999;93-101.
28. Williams G.R., Talbot I.C. Anal carcinoma - a histological review. Histopathology. 25:1994;507-516.
29. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
30. Wong C.S., Tsao M.S., Sharma V., Pintilie M., Cummings B.J. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;309-314.